Project: Integrated Platform for de novo Design and Development of a Chimeric Enzyme for high-value chemicals
The CHImerASE project intends to develop a platform for the design of chimeric enzymes applied to new biotransformation steps. The team aims to deliver an efficient de novo designed enzyme to accomplish a high value industrial transformation that is currently only accessible via a laborious conventional chemical process. The consortium partners strongly believe that such innovative approach will represent a breakthrough in the biocatalysis field with a significant impact at industrial, economical and environmental levels. The multilateral consortium was set up based on the complementary expertise of three academic and non-profit research institutions, a world's leading chemical company which has a top market position in speciality chemicals manufacture and delivery, as well as unique know-how in biotech technology transfer and industrial process scale-up, and a SME biotech with consulting and manufacturing experience of engineered enzymes, resulting in a transnational cooperation between AT, Germany and Portugal.
| Acronym | CHImerASE |
| Website | visit project website |
| Network | ERA-IB-2 |
| Call | 4th ERA-IB Joint Call |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| ATn Centre of Industrial Biotechnology GmbH | Austria | ||
| BASF Group | Germany | ||
| Heinrich Heine University of Düsseldorf | Germany | ||
| Molekulare Biotechnologie | Austria | ||
| New University of Lisbon | Coordinator | Portugal |